Novavax Covid Vaccine seeks FDA Approval

Novavax Covid Vaccine

Novavax, Inc., a biotechnology company, has submitted a request to the FDA to grant Emergency Use Authorization (EUA) to their own Covid vaccine. The Novavax Covid vaccine, NVX-CoV2373, is a protein-based Covid-19 vaccine meant for vaccination in individuals 18 years and above. This is coming after Pfizer filed an approval request for the first-ever vaccine … Read more